 | • レポートコード：QYR2104Z0744 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ベタメタゾンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、医薬品有効成分、錠剤、軟膏、クリーム、ジェル、ローション、その他）、用途別市場規模（全身性外傷性疼痛、メニエール病、難聴、ドライアイ症候群、湿疹、リウマチ、急性白血病、重度気管支喘息、感染症総合治療、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ベタメタゾンの市場動向 ・企業の競争状況、市場シェア ・ベタメタゾンの種類別市場規模（注射剤、医薬品有効成分、錠剤、軟膏、クリーム、ジェル、ローション、その他） ・ベタメタゾンの用途別市場規模（全身性外傷性疼痛、メニエール病、難聴、ドライアイ症候群、湿疹、リウマチ、急性白血病、重度気管支喘息、感染症総合治療、その他） ・ベタメタゾンの北米市場規模2016-2027（アメリカ、カナダ） ・ベタメタゾンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ベタメタゾンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ベタメタゾンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ベタメタゾンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、East West Pharma、Omega Remedies、Moraceae Pharmaceuticals、Emson Medichem、Watson Pharma(Allergan)、Taro Pharmaceuticals、Icn Pharmaceuticals、UCB, Inc、Fougera、Impax (Amneal Pharmaceuticals)、VersaPharm (Akorn)、Nucare Pharmaceuticals、PD-Rx Pharmaceuticals、LEO Pharma、Orbis Biosciences、Surface Pharmaceuticals、Maruho、Dr. Reddy’s、Iroko Pharma、Tianjin Tianyao Pharmaceutical、Tianjin Jinyao Group、Suicheng Pharmaceutical、Shanghai Pharmaceutical、Shandong Shenglu Pharmaceutical、Maanshan Fengyuan Pharmaceutical、Henan Lihua Pharmaceutical、SINOPHARM、Chengdu Mount Tiantai Pharmaceutical、Chenxin Pharmaceutical、Dermocare Laboratories、Cipla、Micro Labs、Pharmtak Ophtalmics、Psyco Remedies） ・結論 |
A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia.
Market Analysis and Insights: Global Betamethasone Market
The global Betamethasone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Betamethasone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Betamethasone market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Betamethasone market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Betamethasone market.
Global Betamethasone Scope and Market Size
Betamethasone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Betamethasone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Active Pharmaceutical Ingredients
Tablets
Ointment
Cream
Gel
Lotion
Other
Segment by Application
Systemic Traumatic Pain
Meniere’s Disease
Hearing Loss
Dry Eye Syndrome
Eczema
Rheumatism
Acute Leukemia
Severe Bronchial Asthma
Comprehensive Treatment Of Infection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
East West Pharma
Omega Remedies
Moraceae Pharmaceuticals
Emson Medichem
Watson Pharma(Allergan)
Taro Pharmaceuticals
Icn Pharmaceuticals
UCB, Inc
Fougera
Impax (Amneal Pharmaceuticals)
VersaPharm (Akorn)
Nucare Pharmaceuticals
PD-Rx Pharmaceuticals
LEO Pharma
Orbis Biosciences
Surface Pharmaceuticals
Maruho
Dr. Reddy’s
Iroko Pharma
Tianjin Tianyao Pharmaceutical
Tianjin Jinyao Group
Suicheng Pharmaceutical
Shanghai Pharmaceutical
Shandong Shenglu Pharmaceutical
Maanshan Fengyuan Pharmaceutical
Henan Lihua Pharmaceutical
SINOPHARM
Chengdu Mount Tiantai Pharmaceutical
Chenxin Pharmaceutical
Dermocare Laboratories
Cipla
Micro Labs
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Betamethasone Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Active Pharmaceutical Ingredients
1.2.4 Tablets
1.2.5 Ointment
1.2.6 Cream
1.2.7 Gel
1.2.8 Lotion
1.2.9 Other
1.3 Market by Application
1.3.1 Global Betamethasone Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Systemic Traumatic Pain
1.3.3 Meniere’s Disease
1.3.4 Hearing Loss
1.3.5 Dry Eye Syndrome
1.3.6 Eczema
1.3.7 Rheumatism
1.3.8 Acute Leukemia
1.3.9 Severe Bronchial Asthma
1.3.10 Comprehensive Treatment Of Infection
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Betamethasone Market Perspective (2016-2027)
2.2 Betamethasone Growth Trends by Regions
2.2.1 Betamethasone Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Betamethasone Historic Market Share by Regions (2016-2021)
2.2.3 Betamethasone Forecasted Market Size by Regions (2022-2027)
2.3 Betamethasone Industry Dynamic
2.3.1 Betamethasone Market Trends
2.3.2 Betamethasone Market Drivers
2.3.3 Betamethasone Market Challenges
2.3.4 Betamethasone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Betamethasone Players by Revenue
3.1.1 Global Top Betamethasone Players by Revenue (2016-2021)
3.1.2 Global Betamethasone Revenue Market Share by Players (2016-2021)
3.2 Global Betamethasone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Betamethasone Revenue
3.4 Global Betamethasone Market Concentration Ratio
3.4.1 Global Betamethasone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Betamethasone Revenue in 2020
3.5 Betamethasone Key Players Head office and Area Served
3.6 Key Players Betamethasone Product Solution and Service
3.7 Date of Enter into Betamethasone Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Betamethasone Breakdown Data by Type
4.1 Global Betamethasone Historic Market Size by Type (2016-2021)
4.2 Global Betamethasone Forecasted Market Size by Type (2022-2027)
5 Betamethasone Breakdown Data by Application
5.1 Global Betamethasone Historic Market Size by Application (2016-2021)
5.2 Global Betamethasone Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Betamethasone Market Size (2016-2027)
6.2 North America Betamethasone Market Size by Type
6.2.1 North America Betamethasone Market Size by Type (2016-2021)
6.2.2 North America Betamethasone Market Size by Type (2022-2027)
6.2.3 North America Betamethasone Market Size by Type (2016-2027)
6.3 North America Betamethasone Market Size by Application
6.3.1 North America Betamethasone Market Size by Application (2016-2021)
6.3.2 North America Betamethasone Market Size by Application (2022-2027)
6.3.3 North America Betamethasone Market Size by Application (2016-2027)
6.4 North America Betamethasone Market Size by Country
6.4.1 North America Betamethasone Market Size by Country (2016-2021)
6.4.2 North America Betamethasone Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Betamethasone Market Size (2016-2027)
7.2 Europe Betamethasone Market Size by Type
7.2.1 Europe Betamethasone Market Size by Type (2016-2021)
7.2.2 Europe Betamethasone Market Size by Type (2022-2027)
7.2.3 Europe Betamethasone Market Size by Type (2016-2027)
7.3 Europe Betamethasone Market Size by Application
7.3.1 Europe Betamethasone Market Size by Application (2016-2021)
7.3.2 Europe Betamethasone Market Size by Application (2022-2027)
7.3.3 Europe Betamethasone Market Size by Application (2016-2027)
7.4 Europe Betamethasone Market Size by Country
7.4.1 Europe Betamethasone Market Size by Country (2016-2021)
7.4.2 Europe Betamethasone Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Betamethasone Market Size (2016-2027)
8.2 Asia-Pacific Betamethasone Market Size by Type
8.2.1 Asia-Pacific Betamethasone Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Betamethasone Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Betamethasone Market Size by Type (2016-2027)
8.3 Asia-Pacific Betamethasone Market Size by Application
8.3.1 Asia-Pacific Betamethasone Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Betamethasone Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Betamethasone Market Size by Application (2016-2027)
8.4 Asia-Pacific Betamethasone Market Size by Region
8.4.1 Asia-Pacific Betamethasone Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Betamethasone Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Betamethasone Market Size (2016-2027)
9.2 Latin America Betamethasone Market Size by Type
9.2.1 Latin America Betamethasone Market Size by Type (2016-2021)
9.2.2 Latin America Betamethasone Market Size by Type (2022-2027)
9.2.3 Latin America Betamethasone Market Size by Type (2016-2027)
9.3 Latin America Betamethasone Market Size by Application
9.3.1 Latin America Betamethasone Market Size by Application (2016-2021)
9.3.2 Latin America Betamethasone Market Size by Application (2022-2027)
9.3.3 Latin America Betamethasone Market Size by Application (2016-2027)
9.4 Latin America Betamethasone Market Size by Country
9.4.1 Latin America Betamethasone Market Size by Country (2016-2021)
9.4.2 Latin America Betamethasone Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Betamethasone Market Size (2016-2027)
10.2 Middle East & Africa Betamethasone Market Size by Type
10.2.1 Middle East & Africa Betamethasone Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Betamethasone Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Betamethasone Market Size by Type (2016-2027)
10.3 Middle East & Africa Betamethasone Market Size by Application
10.3.1 Middle East & Africa Betamethasone Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Betamethasone Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Betamethasone Market Size by Application (2016-2027)
10.4 Middle East & Africa Betamethasone Market Size by Country
10.4.1 Middle East & Africa Betamethasone Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Betamethasone Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Betamethasone Introduction
11.1.4 GlaxoSmithKline Revenue in Betamethasone Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 East West Pharma
11.2.1 East West Pharma Company Details
11.2.2 East West Pharma Business Overview
11.2.3 East West Pharma Betamethasone Introduction
11.2.4 East West Pharma Revenue in Betamethasone Business (2016-2021)
11.2.5 East West Pharma Recent Development
11.3 Omega Remedies
11.3.1 Omega Remedies Company Details
11.3.2 Omega Remedies Business Overview
11.3.3 Omega Remedies Betamethasone Introduction
11.3.4 Omega Remedies Revenue in Betamethasone Business (2016-2021)
11.3.5 Omega Remedies Recent Development
11.4 Moraceae Pharmaceuticals
11.4.1 Moraceae Pharmaceuticals Company Details
11.4.2 Moraceae Pharmaceuticals Business Overview
11.4.3 Moraceae Pharmaceuticals Betamethasone Introduction
11.4.4 Moraceae Pharmaceuticals Revenue in Betamethasone Business (2016-2021)
11.4.5 Moraceae Pharmaceuticals Recent Development
11.5 Emson Medichem
11.5.1 Emson Medichem Company Details
11.5.2 Emson Medichem Business Overview
11.5.3 Emson Medichem Betamethasone Introduction
11.5.4 Emson Medichem Revenue in Betamethasone Business (2016-2021)
11.5.5 Emson Medichem Recent Development
11.6 Watson Pharma(Allergan)
11.6.1 Watson Pharma(Allergan) Company Details
11.6.2 Watson Pharma(Allergan) Business Overview
11.6.3 Watson Pharma(Allergan) Betamethasone Introduction
11.6.4 Watson Pharma(Allergan) Revenue in Betamethasone Business (2016-2021)
11.6.5 Watson Pharma(Allergan) Recent Development
11.7 Taro Pharmaceuticals
11.7.1 Taro Pharmaceuticals Company Details
11.7.2 Taro Pharmaceuticals Business Overview
11.7.3 Taro Pharmaceuticals Betamethasone Introduction
11.7.4 Taro Pharmaceuticals Revenue in Betamethasone Business (2016-2021)
11.7.5 Taro Pharmaceuticals Recent Development
11.8 Icn Pharmaceuticals
11.8.1 Icn Pharmaceuticals Company Details
11.8.2 Icn Pharmaceuticals Business Overview
11.8.3 Icn Pharmaceuticals Betamethasone Introduction
11.8.4 Icn Pharmaceuticals Revenue in Betamethasone Business (2016-2021)
11.8.5 Icn Pharmaceuticals Recent Development
11.9 UCB, Inc
11.9.1 UCB, Inc Company Details
11.9.2 UCB, Inc Business Overview
11.9.3 UCB, Inc Betamethasone Introduction
11.9.4 UCB, Inc Revenue in Betamethasone Business (2016-2021)
11.9.5 UCB, Inc Recent Development
11.10 Fougera
11.10.1 Fougera Company Details
11.10.2 Fougera Business Overview
11.10.3 Fougera Betamethasone Introduction
11.10.4 Fougera Revenue in Betamethasone Business (2016-2021)
11.10.5 Fougera Recent Development
11.11 Impax (Amneal Pharmaceuticals)
11.11.1 Impax (Amneal Pharmaceuticals) Company Details
11.11.2 Impax (Amneal Pharmaceuticals) Business Overview
11.11.3 Impax (Amneal Pharmaceuticals) Betamethasone Introduction
11.11.4 Impax (Amneal Pharmaceuticals) Revenue in Betamethasone Business (2016-2021)
11.11.5 Impax (Amneal Pharmaceuticals) Recent Development
11.12 VersaPharm (Akorn)
11.12.1 VersaPharm (Akorn) Company Details
11.12.2 VersaPharm (Akorn) Business Overview
11.12.3 VersaPharm (Akorn) Betamethasone Introduction
11.12.4 VersaPharm (Akorn) Revenue in Betamethasone Business (2016-2021)
11.12.5 VersaPharm (Akorn) Recent Development
11.13 Nucare Pharmaceuticals
11.13.1 Nucare Pharmaceuticals Company Details
11.13.2 Nucare Pharmaceuticals Business Overview
11.13.3 Nucare Pharmaceuticals Betamethasone Introduction
11.13.4 Nucare Pharmaceuticals Revenue in Betamethasone Business (2016-2021)
11.13.5 Nucare Pharmaceuticals Recent Development
11.14 PD-Rx Pharmaceuticals
11.14.1 PD-Rx Pharmaceuticals Company Details
11.14.2 PD-Rx Pharmaceuticals Business Overview
11.14.3 PD-Rx Pharmaceuticals Betamethasone Introduction
11.14.4 PD-Rx Pharmaceuticals Revenue in Betamethasone Business (2016-2021)
11.14.5 PD-Rx Pharmaceuticals Recent Development
11.15 LEO Pharma
11.15.1 LEO Pharma Company Details
11.15.2 LEO Pharma Business Overview
11.15.3 LEO Pharma Betamethasone Introduction
11.15.4 LEO Pharma Revenue in Betamethasone Business (2016-2021)
11.15.5 LEO Pharma Recent Development
11.16 Orbis Biosciences
11.16.1 Orbis Biosciences Company Details
11.16.2 Orbis Biosciences Business Overview
11.16.3 Orbis Biosciences Betamethasone Introduction
11.16.4 Orbis Biosciences Revenue in Betamethasone Business (2016-2021)
11.16.5 Orbis Biosciences Recent Development
11.17 Surface Pharmaceuticals
11.17.1 Surface Pharmaceuticals Company Details
11.17.2 Surface Pharmaceuticals Business Overview
11.17.3 Surface Pharmaceuticals Betamethasone Introduction
11.17.4 Surface Pharmaceuticals Revenue in Betamethasone Business (2016-2021)
11.17.5 Surface Pharmaceuticals Recent Development
11.18 Maruho
11.18.1 Maruho Company Details
11.18.2 Maruho Business Overview
11.18.3 Maruho Betamethasone Introduction
11.18.4 Maruho Revenue in Betamethasone Business (2016-2021)
11.18.5 Maruho Recent Development
11.18 Dr. Reddy’s
11.25.1 Dr. Reddy’s Company Details
11.25.2 Dr. Reddy’s Business Overview
11.25.3 Dr. Reddy’s Betamethasone Introduction
11.25.4 Dr. Reddy’s Revenue in Betamethasone Business (2016-2021)
11.25.5 Dr. Reddy’s Recent Development
11.20 Iroko Pharma
11.20.1 Iroko Pharma Company Details
11.20.2 Iroko Pharma Business Overview
11.20.3 Iroko Pharma Betamethasone Introduction
11.20.4 Iroko Pharma Revenue in Betamethasone Business (2016-2021)
11.20.5 Iroko Pharma Recent Development
11.21 Tianjin Tianyao Pharmaceutical
11.21.1 Tianjin Tianyao Pharmaceutical Company Details
11.21.2 Tianjin Tianyao Pharmaceutical Business Overview
11.21.3 Tianjin Tianyao Pharmaceutical Betamethasone Introduction
11.21.4 Tianjin Tianyao Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.21.5 Tianjin Tianyao Pharmaceutical Recent Development
11.22 Tianjin Jinyao Group
11.22.1 Tianjin Jinyao Group Company Details
11.22.2 Tianjin Jinyao Group Business Overview
11.22.3 Tianjin Jinyao Group Betamethasone Introduction
11.22.4 Tianjin Jinyao Group Revenue in Betamethasone Business (2016-2021)
11.22.5 Tianjin Jinyao Group Recent Development
11.23 Suicheng Pharmaceutical
11.23.1 Suicheng Pharmaceutical Company Details
11.23.2 Suicheng Pharmaceutical Business Overview
11.23.3 Suicheng Pharmaceutical Betamethasone Introduction
11.23.4 Suicheng Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.23.5 Suicheng Pharmaceutical Recent Development
11.24 Shanghai Pharmaceutical
11.24.1 Shanghai Pharmaceutical Company Details
11.24.2 Shanghai Pharmaceutical Business Overview
11.24.3 Shanghai Pharmaceutical Betamethasone Introduction
11.24.4 Shanghai Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.24.5 Shanghai Pharmaceutical Recent Development
11.25 Shandong Shenglu Pharmaceutical
11.25.1 Shandong Shenglu Pharmaceutical Company Details
11.25.2 Shandong Shenglu Pharmaceutical Business Overview
11.25.3 Shandong Shenglu Pharmaceutical Betamethasone Introduction
11.25.4 Shandong Shenglu Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.25.5 Shandong Shenglu Pharmaceutical Recent Development
11.26 Maanshan Fengyuan Pharmaceutical
11.26.1 Maanshan Fengyuan Pharmaceutical Company Details
11.26.2 Maanshan Fengyuan Pharmaceutical Business Overview
11.26.3 Maanshan Fengyuan Pharmaceutical Betamethasone Introduction
11.26.4 Maanshan Fengyuan Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.26.5 Maanshan Fengyuan Pharmaceutical Recent Development
11.27 Henan Lihua Pharmaceutical
11.27.1 Henan Lihua Pharmaceutical Company Details
11.27.2 Henan Lihua Pharmaceutical Business Overview
11.27.3 Henan Lihua Pharmaceutical Betamethasone Introduction
11.27.4 Henan Lihua Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.27.5 Henan Lihua Pharmaceutical Recent Development
11.28 SINOPHARM
11.28.1 SINOPHARM Company Details
11.28.2 SINOPHARM Business Overview
11.28.3 SINOPHARM Betamethasone Introduction
11.28.4 SINOPHARM Revenue in Betamethasone Business (2016-2021)
11.28.5 SINOPHARM Recent Development
11.29 Chengdu Mount Tiantai Pharmaceutical
11.29.1 Chengdu Mount Tiantai Pharmaceutical Company Details
11.29.2 Chengdu Mount Tiantai Pharmaceutical Business Overview
11.29.3 Chengdu Mount Tiantai Pharmaceutical Betamethasone Introduction
11.29.4 Chengdu Mount Tiantai Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.29.5 Chengdu Mount Tiantai Pharmaceutical Recent Development
11.30 Chenxin Pharmaceutical
11.30.1 Chenxin Pharmaceutical Company Details
11.30.2 Chenxin Pharmaceutical Business Overview
11.30.3 Chenxin Pharmaceutical Betamethasone Introduction
11.30.4 Chenxin Pharmaceutical Revenue in Betamethasone Business (2016-2021)
11.30.5 Chenxin Pharmaceutical Recent Development
11.31 Dermocare Laboratories
11.31.1 Dermocare Laboratories Company Details
11.31.2 Dermocare Laboratories Business Overview
11.31.3 Dermocare Laboratories Betamethasone Introduction
11.31.4 Dermocare Laboratories Revenue in Betamethasone Business (2016-2021)
11.31.5 Dermocare Laboratories Recent Development
11.32 Cipla
11.32.1 Cipla Company Details
11.32.2 Cipla Business Overview
11.32.3 Cipla Betamethasone Introduction
11.32.4 Cipla Revenue in Betamethasone Business (2016-2021)
11.32.5 Cipla Recent Development
11.33 Micro Labs
11.33.1 Micro Labs Company Details
11.33.2 Micro Labs Business Overview
11.33.3 Micro Labs Betamethasone Introduction
11.33.4 Micro Labs Revenue in Betamethasone Business (2016-2021)
11.33.5 Micro Labs Recent Development
11.34 Pharmtak Ophtalmics
11.34.1 Pharmtak Ophtalmics Company Details
11.34.2 Pharmtak Ophtalmics Business Overview
11.34.3 Pharmtak Ophtalmics Betamethasone Introduction
11.34.4 Pharmtak Ophtalmics Revenue in Betamethasone Business (2016-2021)
11.34.5 Pharmtak Ophtalmics Recent Development
11.35 Psyco Remedies
11.35.1 Psyco Remedies Company Details
11.35.2 Psyco Remedies Business Overview
11.35.3 Psyco Remedies Betamethasone Introduction
11.35.4 Psyco Remedies Revenue in Betamethasone Business (2016-2021)
11.35.5 Psyco Remedies Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Betamethasone Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Active Pharmaceutical Ingredients
Table 4. Key Players of Tablets
Table 5. Key Players of Ointment
Table 6. Key Players of Cream
Table 7. Key Players of Gel
Table 8. Key Players of Lotion
Table 9. Key Players of Other
Table 10. Global Betamethasone Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Betamethasone Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Betamethasone Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Betamethasone Market Share by Regions (2016-2021)
Table 14. Global Betamethasone Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Betamethasone Market Share by Regions (2022-2027)
Table 16. Betamethasone Market Trends
Table 17. Betamethasone Market Drivers
Table 18. Betamethasone Market Challenges
Table 19. Betamethasone Market Restraints
Table 20. Global Betamethasone Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Betamethasone Market Share by Players (2016-2021)
Table 22. Global Top Betamethasone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Betamethasone as of 2020)
Table 23. Ranking of Global Top Betamethasone Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Betamethasone Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Betamethasone Product Solution and Service
Table 27. Date of Enter into Betamethasone Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Betamethasone Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Betamethasone Revenue Market Share by Type (2016-2021)
Table 31. Global Betamethasone Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Betamethasone Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Betamethasone Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Betamethasone Revenue Market Share by Application (2016-2021)
Table 35. Global Betamethasone Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Betamethasone Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Betamethasone Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Betamethasone Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Betamethasone Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Betamethasone Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Betamethasone Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Betamethasone Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Betamethasone Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Betamethasone Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Betamethasone Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Betamethasone Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Betamethasone Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Betamethasone Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Betamethasone Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Betamethasone Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Betamethasone Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Betamethasone Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Betamethasone Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Betamethasone Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Betamethasone Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Betamethasone Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Betamethasone Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Betamethasone Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Betamethasone Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Betamethasone Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Betamethasone Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Betamethasone Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Betamethasone Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Betamethasone Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Betamethasone Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Betamethasone Market Size by Country (2022-2027) & (US$ Million)
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Betamethasone Product
Table 70. GlaxoSmithKline Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. East West Pharma Company Details
Table 73. East West Pharma Business Overview
Table 74. East West Pharma Betamethasone Product
Table 75. East West Pharma Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 76. East West Pharma Recent Development
Table 77. Omega Remedies Company Details
Table 78. Omega Remedies Business Overview
Table 79. Omega Remedies Betamethasone Product
Table 80. Omega Remedies Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 81. Omega Remedies Recent Development
Table 82. Moraceae Pharmaceuticals Company Details
Table 83. Moraceae Pharmaceuticals Business Overview
Table 84. Moraceae Pharmaceuticals Betamethasone Product
Table 85. Moraceae Pharmaceuticals Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 86. Moraceae Pharmaceuticals Recent Development
Table 87. Emson Medichem Company Details
Table 88. Emson Medichem Business Overview
Table 89. Emson Medichem Betamethasone Product
Table 90. Emson Medichem Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 91. Emson Medichem Recent Development
Table 92. Watson Pharma(Allergan) Company Details
Table 93. Watson Pharma(Allergan) Business Overview
Table 94. Watson Pharma(Allergan) Betamethasone Product
Table 95. Watson Pharma(Allergan) Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 96. Watson Pharma(Allergan) Recent Development
Table 97. Taro Pharmaceuticals Company Details
Table 98. Taro Pharmaceuticals Business Overview
Table 99. Taro Pharmaceuticals Betamethasone Product
Table 100. Taro Pharmaceuticals Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 101. Taro Pharmaceuticals Recent Development
Table 102. Icn Pharmaceuticals Company Details
Table 103. Icn Pharmaceuticals Business Overview
Table 104. Icn Pharmaceuticals Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 105. Icn Pharmaceuticals Recent Development
Table 106. UCB, Inc Company Details
Table 107. UCB, Inc Business Overview
Table 108. UCB, Inc Betamethasone Product
Table 109. UCB, Inc Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 110. UCB, Inc Recent Development
Table 111. Fougera Company Details
Table 112. Fougera Business Overview
Table 113. Fougera Betamethasone Product
Table 114. Fougera Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 115. Fougera Recent Development
Table 116. Impax (Amneal Pharmaceuticals) Company Details
Table 117. Impax (Amneal Pharmaceuticals) Business Overview
Table 118. Impax (Amneal Pharmaceuticals) Betamethasone Product
Table 119. Impax (Amneal Pharmaceuticals) Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 120. Impax (Amneal Pharmaceuticals) Recent Development
Table 121. VersaPharm (Akorn) Company Details
Table 122. VersaPharm (Akorn) Business Overview
Table 123. VersaPharm (Akorn) Betamethasone Product
Table 124. VersaPharm (Akorn) Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 125. VersaPharm (Akorn) Recent Development
Table 126. Nucare Pharmaceuticals Company Details
Table 127. Nucare Pharmaceuticals Business Overview
Table 128. Nucare Pharmaceuticals Betamethasone Product
Table 129. Nucare Pharmaceuticals Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 130. Nucare Pharmaceuticals Recent Development
Table 131. PD-Rx Pharmaceuticals Company Details
Table 132. PD-Rx Pharmaceuticals Business Overview
Table 133. PD-Rx Pharmaceuticals Betamethasone Product
Table 134. PD-Rx Pharmaceuticals Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 135. PD-Rx Pharmaceuticals Recent Development
Table 136. LEO Pharma Company Details
Table 137. LEO Pharma Business Overview
Table 138. LEO Pharma Betamethasone Product
Table 139. LEO Pharma Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 140. LEO Pharma Recent Development
Table 141. Orbis Biosciences Company Details
Table 142. Orbis Biosciences Business Overview
Table 143. Orbis Biosciences Betamethasone Product
Table 144. Orbis Biosciences Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 145. Orbis Biosciences Recent Development
Table 146. Surface Pharmaceuticals Company Details
Table 147. Surface Pharmaceuticals Business Overview
Table 148. Surface Pharmaceuticals Betamethasone Product
Table 149. Surface Pharmaceuticals Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 150. Surface Pharmaceuticals Recent Development
Table 151. Maruho Company Details
Table 152. Maruho Business Overview
Table 153. Maruho Betamethasone Product
Table 154. Maruho Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 155. Maruho Recent Development
Table 156. Dr. Reddy’s Company Details
Table 157. Dr. Reddy’s Business Overview
Table 158. Dr. Reddy’s Betamethasone Product
Table 159. Dr. Reddy’s Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 160. Dr. Reddy’s Recent Development
Table 161. Iroko Pharma Company Details
Table 162. Iroko Pharma Business Overview
Table 163. Iroko Pharma Betamethasone Product
Table 164. Iroko Pharma Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 165. Iroko Pharma Recent Development
Table 166. Tianjin Tianyao Pharmaceutical Company Details
Table 167. Tianjin Tianyao Pharmaceutical Business Overview
Table 168. Tianjin Tianyao Pharmaceutical Betamethasone Product
Table 169. Tianjin Tianyao Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 170. Tianjin Tianyao Pharmaceutical Recent Development
Table 171. Tianjin Jinyao Group Company Details
Table 172. Tianjin Jinyao Group Business Overview
Table 173. Tianjin Jinyao Group Betamethasone Product
Table 174. Tianjin Jinyao Group Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 175. Tianjin Jinyao Group Recent Development
Table 176. Suicheng Pharmaceutical Company Details
Table 177. Suicheng Pharmaceutical Business Overview
Table 178. Suicheng Pharmaceutical Betamethasone Product
Table 179. Suicheng Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 180. Suicheng Pharmaceutical Recent Development
Table 181. Shanghai Pharmaceutical Company Details
Table 182. Shanghai Pharmaceutical Business Overview
Table 183. Shanghai Pharmaceutical BetamethasoneProduct
Table 184. Shanghai Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 185. Shanghai Pharmaceutical Recent Development
Table 186. Shandong Shenglu Pharmaceutical Company Details
Table 187. Shandong Shenglu Pharmaceutical Business Overview
Table 188. Shandong Shenglu Pharmaceutical Betamethasone Product
Table 189. Shandong Shenglu Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 190. Shandong Shenglu Pharmaceutical Recent Development
Table 191. Maanshan Fengyuan Pharmaceutical Company Details
Table 192. Maanshan Fengyuan Pharmaceutical Business Overview
Table 193. Maanshan Fengyuan Pharmaceutical Betamethasone Product
Table 194. Maanshan Fengyuan Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 195. Maanshan Fengyuan Pharmaceutical Recent Development
Table 196. Henan Lihua Pharmaceutical Company Details
Table 197. Henan Lihua Pharmaceutical Business Overview
Table 198. Henan Lihua Pharmaceutical Betamethasone Product
Table 199. Henan Lihua Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 200. Henan Lihua Pharmaceutical Recent Development
Table 201. SINOPHARM Company Details
Table 202. SINOPHARM Business Overview
Table 203. SINOPHARM Betamethasone Product
Table 204. SINOPHARM Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 205. SINOPHARM Recent Development
Table 206. Chengdu Mount Tiantai Pharmaceutical Company Details
Table 207. Chengdu Mount Tiantai Pharmaceutical Business Overview
Table 208. Chengdu Mount Tiantai Pharmaceutical Betamethasone Product
Table 209. Chengdu Mount Tiantai Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 210. Chengdu Mount Tiantai Pharmaceutical Recent Development
Table 211. Chenxin Pharmaceutical Company Details
Table 212. Chenxin Pharmaceutical Business Overview
Table 213. Chenxin Pharmaceutical Betamethasone Product
Table 214. Chenxin Pharmaceutical Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 215. Chenxin Pharmaceutical Recent Development
Table 216. Dermocare Laboratories Company Details
Table 217. Dermocare Laboratories Business Overview
Table 218. Dermocare Laboratories Betamethasone Product
Table 219. Dermocare Laboratories Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 220. Dermocare Laboratories Recent Development
Table 221. Cipla Company Details
Table 222. Cipla Business Overview
Table 223. Cipla Betamethasone Product
Table 224. Cipla Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 225. Cipla Recent Development
Table 226. Micro Labs Company Details
Table 227. Micro Labs Business Overview
Table 228. Micro Labs Betamethasone Product
Table 229. Micro Labs Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 230. Micro Labs Recent Development
Table 231. Pharmtak Ophtalmics Company Details
Table 232. Pharmtak Ophtalmics Business Overview
Table 233. Pharmtak Ophtalmics Betamethasone Product
Table 234. Pharmtak Ophtalmics Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 235. Pharmtak Ophtalmics Recent Development
Table 236. Psyco Remedies Company Details
Table 237. Psyco Remedies Business Overview
Table 238. Psyco Remedies Betamethasone Product
Table 239. Psyco Remedies Revenue in Betamethasone Business (2016-2021) & (US$ Million)
Table 240. Psyco Remedies Recent Development
Table 241. Research Programs/Design for This Report
Table 242. Key Data Information from Secondary Sources
Table 243. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Betamethasone Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Active Pharmaceutical Ingredients Features
Figure 4. Tablets Features
Figure 5. Ointment Features
Figure 6. Cream Features
Figure 7. Gel Features
Figure 8. Lotion Features
Figure 9. Other Features
Figure 10. Global Betamethasone Market Share by Application: 2020 VS 2027
Figure 11. Systemic Traumatic Pain Case Studies
Figure 12. Meniere's Disease Case Studies
Figure 13. Hearing Loss Case Studies
Figure 14. Dry Eye Syndrome Case Studies
Figure 15. Eczema Case Studies
Figure 16. Rheumatism Case Studies
Figure 17. Acute Leukemia Case Studies
Figure 18. Severe Bronchial Asthma Case Studies
Figure 19. Comprehensive Treatment Of Infection Case Studies
Figure 20. Other Case Studies
Figure 21. Betamethasone Report Years Considered
Figure 22. Global Betamethasone Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 23. Global Betamethasone Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 24. Global Betamethasone Market Share by Regions: 2020 VS 2027
Figure 25. Global Betamethasone Market Share by Regions (2022-2027)
Figure 26. Global Betamethasone Market Share by Players in 2020
Figure 27. Global Top Betamethasone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Betamethasone as of 2020
Figure 28. The Top 10 and 5 Players Market Share by Betamethasone Revenue in 2020
Figure 29. Global Betamethasone Revenue Market Share by Type (2016-2021)
Figure 30. Global Betamethasone Revenue Market Share by Type (2022-2027)
Figure 31. North America Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. North America Betamethasone Market Share by Type (2016-2027)
Figure 33. North America Betamethasone Market Share by Application (2016-2027)
Figure 34. North America Betamethasone Market Share by Country (2016-2027)
Figure 35. United States Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Canada Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Europe Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Europe Betamethasone Market Share by Type (2016-2027)
Figure 39. Europe Betamethasone Market Share by Application (2016-2027)
Figure 40. Europe Betamethasone Market Share by Country (2016-2027)
Figure 41. Germany Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. France Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. U.K. Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Italy Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Russia Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Nordic Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Asia-Pacific Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Asia-Pacific Betamethasone Market Share by Type (2016-2027)
Figure 49. Asia-Pacific Betamethasone Market Share by Application (2016-2027)
Figure 50. Asia-Pacific Betamethasone Market Share by Region (2016-2027)
Figure 51. China Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Japan Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. South Korea Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Southeast Asia Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. India Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Australia Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Latin America Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Latin America Betamethasone Market Share by Type (2016-2027)
Figure 59. Latin America Betamethasone Market Share by Application (2016-2027)
Figure 60. Latin America Betamethasone Market Share by Country (2016-2027)
Figure 61. Mexico Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Brazil Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Middle East & Africa Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Middle East & Africa Betamethasone Market Share by Type (2016-2027)
Figure 65. Middle East & Africa Betamethasone Market Share by Application (2016-2027)
Figure 66. Middle East & Africa Betamethasone Market Share by Country (2016-2027)
Figure 67. Turkey Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 68. Saudi Arabia Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 69. UAE Betamethasone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 71. East West Pharma Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 72. Omega Remedies Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 73. Moraceae Pharmaceuticals Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 74. Emson Medichem Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 75. Watson Pharma(Allergan) Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 76. Taro Pharmaceuticals Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 77. Icn Pharmaceuticals Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 78. UCB, Inc Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 79. Fougera Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 80. Impax (Amneal Pharmaceuticals) Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 81. VersaPharm (Akorn) Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 82. Nucare Pharmaceuticals Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 83. PD-Rx Pharmaceuticals Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 84. LEO Pharma Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 85. Orbis Biosciences Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 86. Surface Pharmaceuticals Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 87. Maruho Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 88. Dr. Reddy’s Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 89. Iroko Pharma Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 90. Tianjin Tianyao Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 91. Tianjin Jinyao Group Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 92. Suicheng Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 93. Shanghai Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 94. Shandong Shenglu Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 95. Maanshan Fengyuan Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 96. Henan Lihua Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 97. SINOPHARM Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 98. Chengdu Mount Tiantai Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 99. Chenxin Pharmaceutical Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 100. Dermocare Laboratories Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 101. Cipla Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 102. Micro Labs Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 103. Pharmtak Ophtalmics Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 104. Psyco Remedies Revenue Growth Rate in Betamethasone Business (2016-2021)
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
世界のクロトリマゾール＆ジプロピオン酸ベタメタゾン市場 2021：企業別、地域別、種類・用途別 The Clotrimazole and Betamethasone Diproprionate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界のメニエール病市場規模・現状・予測（2021年-2027年） Ménière's disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. Typically only one ear is affected, at least initially; however, over time both ears may b…
- 世界の急性感音難聴治療市場規模・現状・予測（2021年-2027年） Acute Sensorineural hearing loss is also known as sudden hearing loss involves an acute unexplained sensorineural hearing loss. Acute Sensorineural hearing loss hearing loss is defined as more than 30 dB hearing decline, over at least three contiguous frequencies, occurring over a period of 72 hours…
- 世界のメニエール病治療薬市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
- 世界のメニエール病治療市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…